PIPELINE THERAPEUTICS Revenue and Competitors
Estimated Revenue & Valuation
- PIPELINE THERAPEUTICS's estimated annual revenue is currently $9.6M per year.
- PIPELINE THERAPEUTICS's estimated revenue per employee is $201,000
Employee Data
- PIPELINE THERAPEUTICS has 48 Employees.
- PIPELINE THERAPEUTICS grew their employee count by 9% last year.
PIPELINE THERAPEUTICS's People
| Name | Title | Email/Phone |
|---|
PIPELINE THERAPEUTICS Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $102.7M | 511 | 25% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $38.6M | 192 | 3% | N/A | N/A |
#4 | $35M | 127 | 2% | $62.5M | N/A |
#5 | $36.6M | 182 | 18% | N/A | N/A |
#6 | $131.9M | 656 | -3% | N/A | N/A |
#7 | $133.5M | 664 | N/A | N/A | N/A |
#8 | $72.8M | 362 | -4% | N/A | N/A |
#9 | $551.9M | 1716 | -2% | N/A | N/A |
#10 | $11.7M | 58 | 12% | N/A | N/A |
What Is PIPELINE THERAPEUTICS?
Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, including synaptogenesis, remyelination and axonal repair. The company's lead product candidate, PIPE-505, is a small molecule gamma secretase inhibitor (GSI) to treat mild-to-moderate sensorineural hearing loss (SNHL) associated with cochlear synaptopathy. The company also has a portfolio of programs, including PIPE-307, focused on remyelination and axonal repair, to address a range of neurological disorders, including multiple sclerosis.
keywords:N/AN/A
Total Funding
48
Number of Employees
$9.6M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
PIPELINE THERAPEUTICS News
Essential HER2 negative Breast Cancer pipeline therapies such as BGB-290, OP-1250, AZD9833, Elacestrant, ADG106, H3B-6545, Dato-DXd,...
Pipeline Therapeutics is a clinical-stage biopharmaceutical company pioneering the development and commercialization of first-in-class...
Pipeline Therapeutics is a clinical-stage biopharmaceutical company pioneering the development and commercialization of first-in-class therapies...
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.8M | 48 | 7% | N/A |
#2 | $5.6M | 48 | N/A | N/A |
#3 | $9.6M | 48 | N/A | N/A |
#4 | $9.6M | 48 | 4% | N/A |
#5 | $9M | 48 | -20% | N/A |
